🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
Open-label, two-arm, prospective multicenter phase II clinical trial to det...
Status
Active Not Recruiting
Location
University Hospital Ulm, Otolaryngology & Head and Neck Surgery
Start Date
2023-05-25
Trial ID
NCT05433116
Treatments Being Tested
The purpose of this study is to test whether the combination of lenvatinib,...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2023-12-29
Trial ID
NCT06110793
Treatments Being Tested
The purpose of this study is to find out whether combining the study drugs,...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2021-03-18
Trial ID
NCT04784247
Treatments Being Tested
This study is being performed as a single-arm open-label study in order to ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07460206
Treatments Being Tested
The prognosis for unresectable and metastatic biliary tract cancers (BTCs) ...
Status
Completed
Location
Shanghai Jiahui International Hospital
Start Date
2021-09-15
Trial ID
NCT04550624
Treatments Being Tested
This study will investigate the efficacy and safety of the combination of p...
Status
Active Not Recruiting
Location
Department of Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University
Start Date
2021-10-27
Trial ID
NCT05078931
Treatments Being Tested
FHRCC is a rare kind of renal cell carcinoma with a morbidity of 1/2000000 ...
Status
Unknown
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-06-01
Trial ID
NCT05877820
Treatments Being Tested
Systemic therapy for renal cell carcinoma (RCC) relies on 2 classes of agen...
Status
Recruiting
Location
Medical University of Vienna
Start Date
2024-04-12
Trial ID
NCT06364631
Treatments Being Tested
This study is designed to evaluate the efficacy of belzutifan in combinatio...
Status
Not Yet Recruiting
Location
Hospital Universitario Reina Sofia
Start Date
2026-06
Trial ID
NCT07593040
Treatments Being Tested